Caris Life Sciences CAI
NASDAQ CAI
$21.67 -1.38 (-5.97%)
As of: Nov 16, 2026 · 11:45 AM EST

Caris Life Sciences (CAI) EV to EBITDA (2025 - 2026)

Updated

Caris Life Sciences' (CAI) EV to EBITDA was 48.20 for Q3 2026, up 104.6% from the prior quarter.

Analysis

Caris Life Sciences (CAI) EV to EBITDA (2025 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, Caris Life Sciences' EV to EBITDA came in at 33.67; for FY2025, it came in at 46.10.

  • Per Business Quant data, the three quarters before Q3 2026 came in at 23.56 (Q2 2026), 29.69 (Q1 2026) and 46.09 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 108.80 Bn 103.16 Bn 17.03 Bn
2 Natera 42.66 Bn 38.28 Bn 513.47 Mn
3 Labcorp Holdings 30.05 Bn 28.13 Bn 1.11 Bn
4 Quest Diagnostics 28.71 Bn 26.48 Bn 1.04 Bn
5 Guardant Health 19.64 Bn 15.26 Bn 236.15 Mn
6 BrightSpring Health Services 14.86 Bn 11.74 Bn 518.55 Mn
7 Encompass Health 13.83 Bn 13.47 Bn 1.54 Bn
8 Tempus AI 12.13 Bn 9.28 Bn 266.70 Mn
9 Universal Health Services 11.56 Bn 11.00 Bn -
10 Caris Life Sciences 6.15 Bn 2.97 Bn 182.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 48.20
Jun 30, 2026 23.56
Mar 31, 2026 29.69
Dec 31, 2025 46.09
API Access

Caris Life Sciences EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=CAI&period=max&api_key=YOUR_API_KEY